Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing authorization for Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first ...
On-site hepatitis C virus testing and treatment with peer support at opioid treatment programs boosts access to curative ...
Maternal hepatitis C virus (HCV) RNA titer > 10⁶ International Units (IU)/mL and antepartum bleeding are key predictors of perinatal transmission, with the risk ranging from 1.5% to 28.5%. The ...
Please provide your email address to receive an email when new articles are posted on . Measurements taken for HCV cure at 4 weeks produced identical results for people who inject drugs as those taken ...
Credit: Cepheid. The Xpert HCV test delivers results in about an hour. The Food and Drug Administration (FDA) has granted marketing authorization to Xpert ® HCV, a point-of-care hepatitis C virus (HCV ...
The FDA has greenlit its first point-of-care diagnostic test for hepatitis C, capable of using only a fingerstick blood sample, in a bid to quickly connect patients with antiviral drugs. “Despite the ...
Compared with enhanced usual care, peer-assisted telemedicine hepatitis C virus (HCV) treatment significantly increased HCV treatment initiation and viral clearance. Hepatitis C virus (HCV) treatment ...
There are persistent gaps in testing-to-treatment linkage and the need for broader access and care coordination among patients with HCV. Only approximately one-third of US adults diagnosed with ...
Men who have sex with men who are living with HIV were found to have a significant burden of both hepatitis B and C infections. Patients who have HIV and HCV or HBV have shown a reduction in life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results